Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Indagine sul Campionamento Venoso Surrenale in Cina (CHAMPION)

6 novembre 2026 aggiornato da: Hui DONG, Chinese Academy of Medical Sciences, Fuwai Hospital

China Adrenal Venous Sampling Investigation: Uno Studio Multicentrico Nazionale

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

Panoramica dello studio

Descrizione dettagliata

Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, yet its optimal diagnostic and therapeutic strategies remain challenging. Adrenal venous sampling (AVS) is regarded as the gold standard for subtype differentiation; however, important clinical, technical, and methodological issues have not been systematically addressed. This study is designed to comprehensively evaluate AVS and its clinical implications, aiming to elucidate the relationship between AVS-guided diagnosis and management of PA and long-term clinical and biochemical outcomes, while refining AVS protocols, standardizing clinical practice, optimizing therapeutic decision-making, and ultimately improving patient management and prognosis.

Tipo di studio

Osservativo

Iscrizione (Stimato)

5000

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Anhui
      • Hefei, Anhui, Cina, 230036
        • Reclutamento
        • The first affiliated hospital of USTC
        • Contatto:
        • Investigatore principale:
          • Xiangyong Kong, PhD
    • Beijing Municipality
      • Beijing, Beijing Municipality, Cina, 100034
        • Reclutamento
        • Peking University First Hospital
        • Investigatore principale:
          • Wei Ma, MD
        • Contatto:
      • Beijing, Beijing Municipality, Cina, 100044
        • Reclutamento
        • Peking University People's Hospital
        • Contatto:
        • Investigatore principale:
          • Jing Liu, MD
      • Beijing, Beijing Municipality, Cina, 100029
        • Reclutamento
        • China-Japan Friendship Hospital
        • Investigatore principale:
          • Wuqiang Che, MD
        • Contatto:
      • Beijing, Beijing Municipality, Cina, 100022
        • Reclutamento
        • Chuiyangliu Hospital affiliated to Tsinghua University
        • Investigatore principale:
          • Lin Pi, MD
        • Contatto:
      • Beijing, Beijing Municipality, Cina, 100037
        • Reclutamento
        • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
        • Investigatore principale:
          • Hui Dong, MD
        • Contatto:
        • Contatto:
      • Beijing, Beijing Municipality, Cina, 101100
        • Reclutamento
        • Beijing Luhe Hospital, Capital Medical University
        • Contatto:
        • Investigatore principale:
          • Dong Zhao, MD, PhD
    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, Cina, 400000
        • Reclutamento
        • Chongqing University Central Hospital
        • Investigatore principale:
          • Dongying Zhang, MD
        • Contatto:
      • Chongqing, Chongqing Municipality, Cina, 401147
        • Reclutamento
        • Chongqing General Hospital
        • Investigatore principale:
          • Rui He, MM
        • Contatto:
      • Chongqing, Chongqing Municipality, Cina, 404100
        • Reclutamento
        • People's Hospital Affiliated to ChongqingThree Gorges Medical college
        • Investigatore principale:
          • Xianhu Luo, MD
        • Contatto:
    • Fujian
      • Fuzhou, Fujian, Cina, 0591-87982222
        • Reclutamento
        • First Affiliated Hospital, Fujian Medical University, Fuzhou, China,
        • Contatto:
        • Investigatore principale:
          • Feng Peng, MD
      • Xiamen, Fujian, Cina, 361016
        • Reclutamento
        • Cardiovascular Hospital Xiamen University
        • Investigatore principale:
          • Tao Ye, MD
        • Contatto:
    • Gansu
      • Lanzhou, Gansu, Cina, 730000
        • Reclutamento
        • Lanzhou University Second Hospital
        • Investigatore principale:
          • Wei Liang, MD
        • Contatto:
    • Guangdong
      • Foshan, Guangdong, Cina, 528211
        • Reclutamento
        • The Forth People's Hosptal of Nanhai District of Foshan City
        • Investigatore principale:
          • Yayan Han, MD
        • Contatto:
      • Guangzhou, Guangdong, Cina, 510080
        • Reclutamento
        • Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
        • Investigatore principale:
          • Yingqing Feng, MD
        • Contatto:
      • Shenzhen, Guangdong, Cina, 518000
        • Reclutamento
        • Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen
        • Contatto:
        • Investigatore principale:
          • Jianqiong Kong, MD
      • Shenzhen, Guangdong, Cina, 518112
        • Reclutamento
        • Shenzhen Third People's Hospital,Shenzhen, Guangdong Province 518112, China
        • Contatto:
          • Zhenzhong Zheng, MD, PhD
          • Numero di telefono: 0755-61222333
          • Email: greateful@163.com
        • Investigatore principale:
          • Zhenzhong Zheng, MD, PhD
      • Shenzhen, Guangdong, Cina, 518116
        • Reclutamento
        • Shenzhen Dapeng New District Kuiyong People's Hospital
        • Investigatore principale:
          • Tongqing Lu, MD
        • Contatto:
    • Guangxi
      • Nanning, Guangxi, Cina, 530000
        • Reclutamento
        • The First Affiliated Hospital of Guangxi Medical University
        • Investigatore principale:
          • Jiangnan Huang, MD
        • Contatto:
      • Nanning, Guangxi, Cina, 530007
        • Reclutamento
        • The Second Affliated Hospital Of GuangXi Medical Univesity
        • Contatto:
        • Investigatore principale:
          • Houfa Ning, MM
      • Nanning, Guangxi, Cina, 547000
        • Reclutamento
        • Nanning Third People's Hospital
        • Contatto:
          • Yongqi Xiao, MBBS
          • Numero di telefono: 07713394390
        • Investigatore principale:
          • Yongqi Xiao, MBBS
    • Guizhou
      • Guiyang, Guizhou, Cina, 550004
        • Reclutamento
        • The Affiliated Hospital of Guizhou Medical University
        • Contatto:
        • Investigatore principale:
          • Zhangrong Chen, MD
      • Guiyang, Guizhou, Cina, 550002
        • Reclutamento
        • Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.
        • Contatto:
        • Investigatore principale:
          • Fang Song, MD
      • Kaili, Guizhou, Cina, 556000
        • Reclutamento
        • The Second Affiliated Hospital Of Guizhou Medical University
        • Investigatore principale:
          • Yumei Xiang, MD
        • Contatto:
    • Hainan
      • Haikou, Hainan, Cina, 570311
        • Reclutamento
        • Hainan General Hospital, Department of Endocrinology
        • Contatto:
        • Investigatore principale:
          • Haiyu Zhang, MM
      • Hainan, Hainan, Cina, 570311
        • Reclutamento
        • Hainan General Hospital, Department of Cardiology
        • Contatto:
        • Investigatore principale:
          • Wang Liao, MD
    • Hebei
      • Tangshan, Hebei, Cina, 063000
        • Reclutamento
        • Tangshan hongci Hospital
        • Investigatore principale:
          • Guijuan Zhang, MD
        • Contatto:
    • Heilongjiang
      • Harbin, Heilongjiang, Cina, 150086
        • Reclutamento
        • The Second Affiliated Hospital of Harbin Medical University
        • Contatto:
        • Investigatore principale:
          • Shuo Zhang, MD
      • Harbin, Heilongjiang, Cina, 150001
        • Reclutamento
        • The First Affiliated Hospital of Harbin Medical University
        • Investigatore principale:
          • Dechao Zhao, MD
        • Contatto:
    • Henan
      • Kaifeng, Henan, Cina, 475002
        • Reclutamento
        • Kai Feng the Peoples Hospital
        • Contatto:
        • Investigatore principale:
          • Qingli Pan, MD
      • Zhengzhou, Henan, Cina, 450052
        • Reclutamento
        • The First Affiliated Hospital of Zhengzhou University
        • Contatto:
        • Investigatore principale:
          • Youyou Du, MD
      • Zhengzhou, Henan, Cina, 450003
        • Reclutamento
        • Henan Provincial People's Hospital
        • Investigatore principale:
          • Min Liu, MD
        • Contatto:
      • Zhengzhou, Henan, Cina, 450000
        • Reclutamento
        • Fuwai Central China Cardiovascular Hospital
        • Investigatore principale:
          • Qiuping Zhao, PhD
        • Contatto:
      • Zhengzhou, Henan, Cina, 450018
        • Reclutamento
        • Zhengzhou Yihe Hospital
        • Contatto:
        • Investigatore principale:
          • Liang An, MD
      • Zhengzhou, Henan, Cina, 450007
        • Reclutamento
        • Zhengzhou Central Hospital Affiliated to Zhengzhou University
        • Investigatore principale:
          • Shuhua Yu, MM
        • Contatto:
      • Zhoukou, Henan, Cina, 466000
        • Reclutamento
        • Zhoukou Central Hospital
        • Investigatore principale:
          • Baogong Wang, MD
        • Contatto:
    • Hubei
      • Wuhan, Hubei, Cina, 430060
        • Reclutamento
        • Renmin Hospital of Wuhan University
        • Contatto:
        • Investigatore principale:
          • Hongxin Xu, MD
      • Xiangyang, Hubei, Cina, 441021
        • Reclutamento
        • Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science
        • Contatto:
        • Investigatore principale:
          • Qingan Li, MD
      • Yichang, Hubei, Cina, 43000
        • Reclutamento
        • Yichang Central People's Hospital
        • Investigatore principale:
          • Yunbo Lv, MD
        • Contatto:
    • Hunan
      • Zhuzhou, Hunan, Cina, 412000
        • Reclutamento
        • Zhuzhou Hospital Affiliated to Xiangya School of Medicine,Central South University
        • Contatto:
          • Liang Tang, MBBS
          • Numero di telefono: 0733-28561703
        • Investigatore principale:
          • Liang Tang, MBBS
    • Jiangsu
      • Xuzhou, Jiangsu, Cina, 221009
        • Reclutamento
        • Xuzhou Central Hospital, Jiangsu
        • Contatto:
        • Investigatore principale:
          • Hongyun Ruan, MD
    • Jiangxi
      • Ganzhou, Jiangxi, Cina, 341000
        • Reclutamento
        • The First Affiliated Hospital of Gannan Medical University
        • Contatto:
        • Investigatore principale:
          • Jiayuan Yuan, MD
      • Nanchang, Jiangxi, Cina, 330006
        • Reclutamento
        • Second Affiliated Hospital of Nanchang University
        • Contatto:
        • Investigatore principale:
          • Yifei Dong, MD, PhD
      • Nanchang, Jiangxi, Cina, 330038
        • Reclutamento
        • Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
        • Investigatore principale:
          • Haohang Ruan, MBBS
        • Contatto:
          • Haohang Ruan, MBBS
          • Numero di telefono: 0791-87721036
    • Jilin
      • Changchun, Jilin, Cina, 130021
        • Reclutamento
        • The First Hospital of Jilin University
        • Contatto:
        • Investigatore principale:
          • Wei Zhao, MD
      • Changchun, Jilin, Cina, 130051
        • Reclutamento
        • Jilin Province FAW General Hospital
        • Investigatore principale:
          • Wenhai Wang, MM
        • Contatto:
    • Liaoning
      • Dalian, Liaoning, Cina, 116001
        • Reclutamento
        • Affilated Zhongshan Hospital of Dalian University
        • Contatto:
        • Investigatore principale:
          • Minglian Gong, MD
      • Dalian, Liaoning, Cina, 116011
        • Reclutamento
        • Frist Aiffiliated Hospital of Dalian Medical University
        • Investigatore principale:
          • Yinong Jiang, MD
        • Contatto:
      • Dalian, Liaoning, Cina, 116027
        • Reclutamento
        • The second hospital of Dalian Medical University
        • Contatto:
        • Investigatore principale:
          • Nan Niu, MD
    • Neimenggu
      • Ulanhot, Neimenggu, Cina, 137400
        • Reclutamento
        • Inner Mongolia Xing'an League People's Hospital
        • Contatto:
        • Investigatore principale:
          • Tao Guo, MM
    • Ningxia
      • Yinchuan, Ningxia, Cina, 750000
        • Reclutamento
        • The First People's Hospital of Yinchuan
        • Contatto:
        • Investigatore principale:
          • Fang Chen, PhD
    • Qinghai
      • Xining, Qinghai, Cina, 810001
        • Reclutamento
        • Qinghai University Affiliated Hospital
        • Contatto:
        • Investigatore principale:
          • Ming Ren, MM
      • Xining, Qinghai, Cina, 810000
        • Reclutamento
        • Qinghai Province Cardiovascular and Cerebrovascular Disease Specialist Hospital
        • Contatto:
        • Investigatore principale:
          • Xiaozhou Wang, MD
    • Shandong
      • Jinan, Shandong, Cina, 250012
        • Reclutamento
        • Qilu Hospital of Shandong University
        • Investigatore principale:
          • Peili Bu, MD
        • Contatto:
      • Jinan, Shandong, Cina, 250013
        • Reclutamento
        • Central Hospital Affiliated to Shandong First Medical University
        • Contatto:
        • Investigatore principale:
          • Rui Xu, MD, PhD
      • Jinan, Shandong, Cina, 250000
        • Reclutamento
        • the Second Hospital, Cheeloo College of Medicine, Shandong University
        • Contatto:
        • Investigatore principale:
          • Qinghai Wang, MD
      • Liaocheng, Shandong, Cina, 252200
        • Reclutamento
        • People's Hospital of Donga County, Shandong Province
        • Investigatore principale:
          • Xiaoli Wang, MD
        • Contatto:
      • Qingdao, Shandong, Cina, 266000
        • Reclutamento
        • Qingdao Hospital University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital)
        • Contatto:
        • Investigatore principale:
          • Nan Jia, MD
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Cina, 200025
        • Reclutamento
        • Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        • Contatto:
        • Investigatore principale:
          • Jianzhong Xu, MD, PhD
      • Shanghai, Shanghai Municipality, Cina, 200062
        • Reclutamento
        • Shanghai Putuo District Central Hospital
        • Investigatore principale:
          • Zongjun Liu, MD
        • Contatto:
      • Shanghai, Shanghai Municipality, Cina, 200080
        • Reclutamento
        • Shanghai General Hospital ( originally named Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine
        • Contatto:
        • Investigatore principale:
          • Zhi Zhang, MD
    • Shanxi
      • Taiyuan, Shanxi, Cina, 030001
        • Reclutamento
        • the second hospital of ShanXi medical unversity
        • Investigatore principale:
          • Bin Yang, MD
        • Contatto:
      • Xi’an, Shanxi, Cina, 710018
        • Reclutamento
        • Xi'an People's Hospital
        • Contatto:
        • Investigatore principale:
          • Kang Cheng, MD, PhD
    • Sichuan
      • Chengdu, Sichuan, Cina, 611130
        • Reclutamento
        • Chengdu Fifth People's Hospital
        • Investigatore principale:
          • Mingjian Lang, MD
        • Contatto:
          • Mingjian Lang
          • Numero di telefono: (028) 8271 0681
          • Email: zcl628@163.com
      • Chengdu, Sichuan, Cina, 610500
        • Reclutamento
        • The First Affiliated Hospital of Chengdu Medical College
        • Investigatore principale:
          • Peijian Wang, MD
        • Contatto:
      • Chengdu, Sichuan, Cina, 610031
        • Reclutamento
        • The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China
        • Investigatore principale:
          • Zhen Zhang, MD
        • Contatto:
    • Tianjin Municipality
      • Tianjin, Tianjin Municipality, Cina, 300052
        • Reclutamento
        • Tianjin Medical University General Hospital
        • Investigatore principale:
          • Dianxun Fu, MD
        • Contatto:
      • Tianjin, Tianjin Municipality, Cina, 300211
        • Reclutamento
        • The Second Hospital of Tianjin Medical University
        • Investigatore principale:
          • Changle Liu, MD
        • Contatto:
      • Tianjin, Tianjin Municipality, Cina, 300457
        • Reclutamento
        • TEDA International Cardiovascular Hospital
        • Contatto:
        • Investigatore principale:
          • Weiqiang Wang, MM
    • Tibet
      • Chamdo, Tibet, Cina, 854000
        • Reclutamento
        • Changdu People's Hospital of Tibet
        • Contatto:
          • Rui Xiang, MD
          • Numero di telefono: 0895-4821745
        • Investigatore principale:
          • Rui Xiang, MD
    • Xinjiang
      • Yining, Xinjiang, Cina, 835000
        • Reclutamento
        • Yili Kazak Autonomous Prefecture Friendship Hospital
        • Contatto:
        • Investigatore principale:
          • Wei Li, MBBS
      • Ürümqi, Xinjiang, Cina, 830001
        • Reclutamento
        • Xinjiang Uygur Autonomous Region People's Hospital
        • Contatto:
        • Investigatore principale:
          • Guoliang Wang, PhD
    • Yunnan
      • Kunming, Yunnan, Cina, 650031
        • Reclutamento
        • The First Affiliated Hospital of Kunming Medical University
        • Contatto:
        • Investigatore principale:
          • Lihua Zhang, PhD
      • Kunming, Yunnan, Cina, 650102
        • Reclutamento
        • Fuwai Yunnan Cardiovascular Hospital
        • Investigatore principale:
          • Zihong Guo, MD
        • Contatto:
      • Kunming, Yunnan, Cina, 650051
        • Reclutamento
        • Yan'an Affiliated Hospital of Kunming Medical University
        • Contatto:
        • Investigatore principale:
          • Yan He, MD
    • Zhejiang
      • Hangzhou, Zhejiang, Cina, 310000
        • Reclutamento
        • Zhejiang Hospital
        • Investigatore principale:
          • Yimin Tang, MD
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

All patients with confirmed primary aldosteronism underwent adrenal venous sampling.

Descrizione

Inclusion Criteria:

  1. Patients with confirmed primary aldosteronism;
  2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism.

Exclusion Criteria:

  1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months;
  2. An estimated glomerular filtration rate <45 ml/min/1.73 m2, or serum creatinine >176 μmol/L;
  3. Patients who refuse adrenalectomy;
  4. Suspected of having an adrenocortical carcinoma;
  5. Allergy to contrast agent;
  6. Pregnant, nursing, or planning to become pregnant

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: OTHER

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Adrenal Venous Sampling

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Patients with Primary Aldosteronism (PA) undergoing Adrenal Venous Sampling via antecubital approach or femoral approach to discriminate PA forms with unilateral from bilateral excess aldosterone production.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Major adverse cardiovascular events (MACE) at 1-year follow-up
Lasso di tempo: 1 year after AVS procedure

Incidence of major adverse cardiovascular events (MACE) at 1-year follow-up, including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

1 year after AVS procedure

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The success rate of left adrenal venous sampling
Lasso di tempo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of right adrenal venous sampling
Lasso di tempo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
The success rate of bilateral adrenal venous sampling
Lasso di tempo: At AVS procedure

Successful sampling will be defined by high selectivity index (cortisol in the adrenal vein/cortisol in inferior vena cava >2 without ACTH simulation)

At AVS procedure
Selection of intraoperative catheter
Lasso di tempo: At AVS procedure

Types of catheter at the time of Adrenal Venous Sampling via antecubital approach or femoral approach

At AVS procedure
Time of the procedure
Lasso di tempo: At AVS procedure

Time of the procedure

At AVS procedure
Time of fluoroscopy
Lasso di tempo: At AVS procedure

Time of fluoroscopy

At AVS procedure
The contrast agent dosage
Lasso di tempo: At AVS procedure

The contrast agent dosage

At AVS procedure
the incidence of complications
Lasso di tempo: 1 week after AVS procedure

Complications related to adrenal vein cannulations (adrenal vein hematoma, inferior vena cava dissection, puncture site hematoma, etc)

1 week after AVS procedure
the cost of the procedure
Lasso di tempo: At AVS procedure

the cost of the procedure

At AVS procedure
Change in 24-hour ambulatory systolic blood pressure
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average systolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) between baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in 24-hour ambulatory diastolic blood pressure
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in average diastolic blood pressure measured by 24-hour ambulatory blood pressure monitoring (ABPM) bewteen baseline and each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office systolic blood pressure
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in systolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in office diastolic blood pressure
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in diastolic blood pressure measured during clinic visits (office blood pressure) between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in antihypertensive medication burden
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in the number and/or dosage of antihypertensive medications taken by patients between baseline and each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in urinary albumin-to-creatinine ratio (UACR)
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The difference in urinary albumin-to-creatinine ratio measured at baseline and at each follow-up time point

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in left ventricular mass index (LVMI)
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in left ventricular mass index, as assessed by echocardiography, from baseline to each follow-up time point.

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Change in pulse wave velocity (PWV) from baseline
Lasso di tempo: At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment

The change in pulse wave velocity measured between baseline and each follow-up time point。

At 1, 3, 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after treatment
Clinical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Lasso di tempo: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Clinical outcomes will be assessed at each follow-up visit afteradrenal surgery according to the PASO consensus criteria. Outcomes will be categorized as:

(1)Complete clinical success: normal blood pressure without the need for any antihypertensive medication. (2)Partial clinical success: improvement in blood pressure and/or a reduction in the number or dosage of antihypertensive medications. (3)Absent clinical success: no improvement in blood pressure or antihypertensive medication burden.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Biochemical Outcome According to Primary Aldosteronism Surgical Outcome (PASO) Criteria
Lasso di tempo: At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery

Biochemical outcomes will be assessed at each follow-up visit after adrenal surgery according to the PASO consensus classification. Outcomes will be categorized as:(1)Complete biochemical success: normal serum potassium levels and a normalized aldosterone-to-renin ratio (ARR) without the need for potassium supplementation.(2)Partial biochemical success: improvement in biochemical parameters without full normalization.(3)Absent biochemical success: no improvement in biochemical markers compared to baseline.

At 6, 12, and 18 months; and 2, 3, 4, 5, and 10 years after surgery
Major adverse cardiovascular events (MACE)
Lasso di tempo: At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Incidence of major adverse cardiovascular events (MACE), including stroke, heart failure, severe arrhythmias, renal failure, myocardial infarction, and death.

At 6 and 18 months; and 2, 3, 4, 5, and 10 years after AVS procedure

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Hui Dong, MD, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 dicembre 2025

Completamento primario (Stimato)

31 agosto 2029

Completamento dello studio (Stimato)

31 agosto 2029

Date di iscrizione allo studio

Primo inviato

19 novembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

19 novembre 2025

Primo Inserito (Effettivo)

26 novembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

10 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

6 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi